MIRANDOLA LEONARDO enters KIROMIC BIOPHARMA, INC. with 56.93K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/9/2024ACC: 0001104659-24-059463
Officer· CSO
Since May 2024
56.93K
Baseline shares
100% direct
56.93K
Direct ownership
2 positions
143.00
Derivative underlying
2 instruments
2
Security positions
All direct
Non-Derivative Holdings2
Restricted Stock Award
DirectShares owned56.91K
Restricted Stock Award
DirectShares owned15.00
Total
56.93K direct56.93K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Stock Award | 56.91K | Direct |
| Restricted Stock Award | 15.00 | Direct |
| Total | 56.93K | 56.93K direct |
Derivative Holdings2
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
115.00
Shares owned
N/A
Exercise price
199.20
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
28.00
Shares owned
N/A
Exercise price
0.00
Expiration
—
Exercise window
—
Total
Underlying
143.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 199.20 | — | — | 115.00 | N/A |
| Restricted Stock Units Direct | Common Stock | 0.00 | — | — | 28.00 | N/A |
| Total | 143.00 | 0.00 | ||||